Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...

DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data and powerful ...

In addition to Canaccord Genuity, Dexcom also received a Buy from TD Cowen’s Josh Jennings in a report issued yesterday. However, on the same day, Barclays reiterated a Sell rating on Dexcom (NASDAQ: ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

Shares rose 6.4% to $71.73, putting the stock on pace for its highest close since September, according to Dow Jones Market ...

(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.17%, ...

In response to this consumer enthusiasm, health systems are pouring resources into wearable device programs that promise continuous insight into patients’ health. These devices can monitor everything ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical ...